101 related articles for article (PubMed ID: 9761393)
1. Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families.
Osorio A; Robledo M; Martínez B; Cebrián A; San Román JM; Albertos J; Lobo F; Benítez J
Clin Genet; 1998 Aug; 54(2):142-7. PubMed ID: 9761393
[TBL] [Abstract][Full Text] [Related]
2. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
3. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.
Schubert EL; Lee MK; Mefford HC; Argonza RH; Morrow JE; Hull J; Dann JL; King MC
Am J Hum Genet; 1997 May; 60(5):1031-40. PubMed ID: 9150150
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the BRCA2 gene in breast/ovarian cancer Spanish families: identification of two new mutations.
Osorio A; Robledo M; San Román JM; Albertos J; Andrade J; Barabash A; Benítez J
Cancer Lett; 1997 Dec; 121(2):115-8. PubMed ID: 9570347
[TBL] [Abstract][Full Text] [Related]
5. Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain.
Campos B; Díez O; Odefrey F; Domènech M; Moncoutier V; Martínez-Ferrandis JI; Osorio A; Balmaña J; Barroso A; Armengod ME; Benítez J; Alonso C; Stoppa-Lyonnet D; Goldgar D; Baiget M
Hum Mutat; 2003 Apr; 21(4):452. PubMed ID: 12655574
[TBL] [Abstract][Full Text] [Related]
6. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
[TBL] [Abstract][Full Text] [Related]
7. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
Ganguly T; Dhulipala R; Godmilow L; Ganguly A
Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
9. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
[TBL] [Abstract][Full Text] [Related]
10. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
Neuhausen SL; Godwin AK; Gershoni-Baruch R; Schubert E; Garber J; Stoppa-Lyonnet D; Olah E; Csokay B; Serova O; Lalloo F; Osorio A; Stratton M; Offit K; Boyd J; Caligo MA; Scott RJ; Schofield A; Teugels E; Schwab M; Cannon-Albright L; Bishop T; Easton D; Benitez J; King MC; Ponder BA; Weber B; Devilee P; Borg A; Narod SA; Goldgar D
Am J Hum Genet; 1998 Jun; 62(6):1381-8. PubMed ID: 9585613
[TBL] [Abstract][Full Text] [Related]
11. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
12. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi OP; Winqvist R; Nevanlinna H
Eur J Hum Genet; 2000 Oct; 8(10):757-63. PubMed ID: 11039575
[TBL] [Abstract][Full Text] [Related]
13. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
[TBL] [Abstract][Full Text] [Related]
14. A low proportion of BRCA2 mutations in Finnish breast cancer families.
Vehmanen P; Friedman LS; Eerola H; Sarantaus L; Pyrhönen S; Ponder BA; Muhonen T; Nevanlinna H
Am J Hum Genet; 1997 May; 60(5):1050-8. PubMed ID: 9150152
[TBL] [Abstract][Full Text] [Related]
15. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
Berman DB; Costalas J; Schultz DC; Grana G; Daly M; Godwin AK
Cancer Res; 1996 Aug; 56(15):3409-14. PubMed ID: 8758903
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090
[TBL] [Abstract][Full Text] [Related]
17. BRCA2 germ-line mutations in Spanish male breast cancer patients.
Díez O; Cortés J; Domènech M; Pericay C; Brunet J; Alonso C; Baiget M
Ann Oncol; 2000 Jan; 11(1):81-4. PubMed ID: 10690392
[TBL] [Abstract][Full Text] [Related]
18. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
19. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
20. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
Thorlacius S; Olafsdottir G; Tryggvadottir L; Neuhausen S; Jonasson JG; Tavtigian SV; Tulinius H; Ogmundsdottir HM; Eyfjörd JE
Nat Genet; 1996 May; 13(1):117-9. PubMed ID: 8673089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
